NDC 66019-305-10 Flumist Quadrivalent

Influenza Vaccine Live Intranasal

NDC Package Code 66019-305-10

Field Name Field Value
NDC Code 66019-305-10
Package Description 10 APPLICATOR in 1 PACKAGE > .2 mL in 1 APPLICATOR (66019-305-01)
Proprietary Name Flumist Quadrivalent Additional informationCallout TooltipWhat is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Influenza Vaccine Live Intranasal Additional informationCallout TooltipWhat is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
11-Digit NDC Billing Format 66019030510 Additional informationCallout TooltipNDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
Billing Unit EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Product Type Vaccine Additional informationCallout TooltipWhat kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Labeler Name Medimmune, Llc
Dosage Form Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route(s)
  • Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
  • INFLUENZA A VIRUS A/SLOVENIA/2903/2015 (H1N1) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL
  • INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 (H3N2) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL
  • INFLUENZA B VIRUS B/COLORADO/06/2017 LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL
Marketing Category BLA - A product marketed under an approved Biologic License Application. Additional informationCallout TooltipWhat is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
FDA Application Number BLA125020 Additional informationCallout TooltipWhat is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Start Marketing Date 08-10-2018 Additional informationCallout TooltipWhat is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

The NDC Code 66019-305-10 is assigned to Flumist Quadrivalent, a vaccine lable labeled by Medimmune, Llc. The product's dosage form is spray and is administered via nasal form.


Code Structure
  • 66019 - Medimmune, Llc
    • 66019-305 - Flumist Quadrivalent
      • 66019-305-10 - 10 APPLICATOR in 1 PACKAGE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

NDC HCPCS Crosswalk

This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

NDC 66019-305-10 HCPCS crosswalk information with package details and bill units information.

NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
6601903051090672Laiv4 vaccine intranasal0.2 ml0.2 ML10110

* Please review the disclaimer below.

Previous Code
66010-515
Next Code
66051-011